Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 0	$ 0
Expenses:
Consulting	0	0
Research and development	345,463	132,724
Selling, general and administrative (Note 8)	96,253	83,406
Stock-based compensation (Note 7)	139,648	177,490
Total expenses	581,364	393,620
Loss from operations	(581,364)	(393,620)
Other income
Interest income	0	0
Net Loss	(581,364)	(393,620)
Other comprehensive loss
Currency translation differences	(4,022)	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total	(4,022)	0
Total Comprehensive Loss	$ (585,386)	$ (393,620)
Net loss per share - basic and diluted (in dollars per share)	$ (1)	$ (0)
Weighted-average number of common shares outstanding - basic and diluted (in shares)	91,422,569	86,522,569